Adrian Kinkaid- CEO, MIP Diagnostics Limited

  • Presentation Title:

    Molecularly Imprinted Polymers: Robust affinity reagents for applications from processing to quality control and environmental protection.

    Presentation Synopsis:

    Molecularly imprinted polymers are a novel form of affinity reagent sometimes called “plastic antibodies”. They can be made to recognise and bind virtually any molecular target and offer a more robust alternative to biological agents such as antibodies. They can be made to withstand diverse conditions including exposure to organic solvents, extremes of temperature and pH or ionic content. Based on a non-degradable polyethylene backbone they can be used in applications where antibodies etc. would be unsuitable. MIPs have been used to harvest high value natural products from plant matter and salvage pharmaceutical materials from waste.

    Speaker Bio:

    Adrian has extensive experience in the life sciences sector, with particular expertise in affinity reagents, including antibodies, affimers and aptamers. He has developed a thorough understanding of the field and considers MIPs as a cost effective and high quality alternative to existing reagents due especially to their robustness and speed of development.

    Prior to joining MIP Diagnostics, Adrian worked as Chief Commercial Officer for Promexus, a protein biotherapeutics company based on affimer technology from Avacta Life Sciences. Before this he was Head of Technology Access and then Strategic Market Development Leader for Abcam, the leading provider of research antibodies.

    Adrian’s industrial experience started with agrochemical and pharmaceutical discovery where he developed a range of different biochemical and cell based assays mainly for high throughput screening applications. Adrian is also a Founding Member of ELRIG (European Laboratory Research and Innovation Group) a not-for-profit organisation that holds conferences and events for thought leadership in the life science and drug discovery communities. Adrian served two terms as Chairman, during which time he established the flagship Drug Discovery event, which is now the leading conference of its kind in Europe.

    www.mip-dx.com

  • Register Now:

     

    First Name (required)

    Second Name (required)

    Company Name (required)

    Job Title (required)

    Contact Email (required)

    Phone Number (required)

    Promotional Code

    How did you hear about event

    agreed Tick box to agree to the our privacy policy. You can opt out at any time. We never share your details Privacy Policy